Literature DB >> 19629056

Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin.

Caren E Smith1, Katherine L Tucker, Chao-Qiang Lai, Laurence D Parnell, Yu-Chi Lee, José M Ordovás.   

Abstract

Apolipoprotein A5 (APOA5) and lipoprotein lipase (LPL) proteins interact functionally to regulate lipid metabolism, and single-nucleotide polymorphisms (SNPs) for each gene have also been associated independently with obesity risk. Evaluating gene combinations may be more effective than single SNP analyses in identifying genetic risk, but insufficient minor allele frequency (MAF) often limits evaluations of potential epistatic relationships. Populations with multiple ancestral admixtures may provide unique opportunities for evaluating genetic interactions. We examined relationships between LPL m107 (rs1800590) and APOA5 S19W (rs3135506) and lipid and anthropometric measures in Caribbean origin Hispanics (n = 1,019, aged 45-75 years) living in the Boston metropolitan area. Significant interaction terms between LPL m107 and APOA5 S19W were observed for BMI (P = 0.003) and waist circumference (P = 0.019). Higher BMI (P = 0.001), waist (P = 0.011) and hip (P = 0.026) circumference were observed in minor allele (G) carriers for LPL m107 who also carried the APOA5 S19W minor allele (G). Additionally, extreme obesity (BMI > or = 40 kg/m(2)) risk was higher (odds ratio = 4.02; 95% confidence interval: 1.81-8.91; global P = 0.008) for minor allele carriers for both SNPs (LPL TG+GG, APOA5 CG+GG) compared to major allele carriers for both SNPs. In summary, we identified significant interactions for APOA5 S19W and LPL m107 for obesity in Caribbean Hispanics. Population-specific MAFs increase the difficulties of replicating gene-gene interactions, but may support the hypothesis that combinations of frequencies in selected genes could heighten obesity susceptibility in a given population. Analyses of gene-gene interactions may improve understanding of genetically based obesity risk, and underscore the need for further study of groups with multiple ancestral admixtures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629056      PMCID: PMC2813926          DOI: 10.1038/oby.2009.216

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  36 in total

1.  Contribution of several candidate gene polymorphisms in the determination of adiposity changes: results from the Québec Family Study.

Authors:  L Bouchard; A Tremblay; C Bouchard; L Pérusse
Journal:  Int J Obes (Lond)       Date:  2007-02-13       Impact factor: 5.095

2.  APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study.

Authors:  Dolores Corella; Chao-Qiang Lai; Serkalem Demissie; L Adrienne Cupples; Alisa K Manning; Katherine L Tucker; Jose M Ordovas
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

3.  Mortality and cardiac and vascular outcomes in extremely obese women.

Authors:  Kathleen McTigue; Joseph C Larson; Alice Valoski; Greg Burke; Jane Kotchen; Cora E Lewis; Marcia L Stefanick; Linda Van Horn; Lewis Kuller
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

4.  Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.

Authors:  Mark O Goodarzi; Kent D Taylor; Xiuqing Guo; John E Hokanson; Steven M Haffner; Jinrui Cui; Yii-Der I Chen; Lynne E Wagenknecht; Richard N Bergman; Jerome I Rotter
Journal:  J Clin Endocrinol Metab       Date:  2006-10-10       Impact factor: 5.958

5.  Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population.

Authors:  V Radha; K S Vimaleswaran; K Ashok Ayyappa; V Mohan
Journal:  Int J Obes (Lond)       Date:  2007-02-13       Impact factor: 5.095

6.  Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study.

Authors:  S Li; W Chen; S R Srinivasan; E Boerwinkle; G S Berenson
Journal:  Int J Obes (Lond)       Date:  2006-03-14       Impact factor: 5.095

7.  A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases.

Authors:  Jian Wang; Sanjay Shete
Journal:  Am J Hum Genet       Date:  2008-06-26       Impact factor: 11.025

8.  Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and -1131C.

Authors:  J Kovář; V Adámková
Journal:  Physiol Res       Date:  2007-07-26       Impact factor: 1.881

9.  Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.

Authors:  Loredan Stefan Niculescu; Jamila Fruchart-Najib; Jean-Charles Fruchart; Anca Sima
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

10.  Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.

Authors:  Giriraj R Chandak; Kirsten J Ward; Chittaranjan S Yajnik; Anand N Pandit; Ashish Bavdekar; Charu V Joglekar; Caroline H D Fall; P Mohankrishna; Terence J Wilkin; Bradley S Metcalf; Michael N Weedon; Timothy M Frayling; Andrew T Hattersley
Journal:  BMC Med Genet       Date:  2006-10-10       Impact factor: 2.103

View more
  8 in total

Review 1.  Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.

Authors:  Jaroslav A Hubacek
Journal:  Gene       Date:  2016-08-02       Impact factor: 3.688

Review 2.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

3.  Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.

Authors:  Yan-Yan Li; Xiao-Yan Wu; Jian Xu; Yun Qian; Chuan-Wei Zhou; Bei Wang
Journal:  Mol Biol Rep       Date:  2012-11-06       Impact factor: 2.316

4.  A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.

Authors:  Aldi T Kraja; Dhananjay Vaidya; James S Pankow; Mark O Goodarzi; Themistocles L Assimes; Iftikhar J Kullo; Ulla Sovio; Rasika A Mathias; Yan V Sun; Nora Franceschini; Devin Absher; Guo Li; Qunyuan Zhang; Mary F Feitosa; Nicole L Glazer; Talin Haritunians; Anna-Liisa Hartikainen; Joshua W Knowles; Kari E North; Carlos Iribarren; Brian Kral; Lisa Yanek; Paul F O'Reilly; Mark I McCarthy; Cashell Jaquish; David J Couper; Aravinda Chakravarti; Bruce M Psaty; Lewis C Becker; Michael A Province; Eric Boerwinkle; Thomas Quertermous; Leena Palotie; Marjo-Riitta Jarvelin; Diane M Becker; Sharon L R Kardia; Jerome I Rotter; Yii-Der Ida Chen; Ingrid B Borecki
Journal:  Diabetes       Date:  2011-03-08       Impact factor: 9.461

5.  Global O-GlcNAc Levels Modulate Transcription of the Adipocyte Secretome during Chronic Insulin Resistance.

Authors:  Edith E Wollaston-Hayden; Ruth B S Harris; Bingqiang Liu; Robert Bridger; Ying Xu; Lance Wells
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-22       Impact factor: 5.555

Review 6.  New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.

Authors:  Xin Su; Yi Kong; Dao-Quan Peng
Journal:  Lipids Health Dis       Date:  2018-07-27       Impact factor: 3.876

7.  Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster.

Authors:  M-C Hsu; C-S Chang; K-T Lee; H-Y Sun; Y-S Tsai; P-H Kuo; K-C Young; C-H Wu
Journal:  Nutr Diabetes       Date:  2013-03-04       Impact factor: 5.097

8.  Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study.

Authors:  Sohrab Halalkhor; Farzad Jalali; Karimollah Hajian Tilaki; Shahla Shojaei
Journal:  J Diabetes Metab Disord       Date:  2014-04-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.